{"id":"W4404532483","doi":"10.1093/bjd/ljae454","title":"Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Portugal; Janssen Australia; Caisse nationale de l'Assurance Maladie; Bristol-Myers Squibb Canada; AbbVie Canada; Psoriasis Association; LEO Pharma; Assistance publique-Hôpitaux de Paris; Cilag; University of Manchester; British Association of Dermatologists; Almirall; Boehringer Ingelheim España; Assistance Publique - Hôpitaux de Paris; Manchester Biomedical Research Centre","keywords":"Biosimilar; Adalimumab; Medicine; Psoriasis; Multinational corporation; Cohort; Internal medicine; Cohort study; Oncology; Family medicine; Dermatology; Business; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000681839,0.0001487503,0.0007223734,0.0001575435,0.0001292877,0.00003458748,0.0001491738,0.0001412618,0.00008582582],"category_scores_gemma":[0.0001930782,0.000125161,0.0001258918,0.000165524,0.0003159332,0.00009936914,0.00003887946,0.0002977845,8.64652e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002794975,"about_ca_system_score_gemma":0.0001178649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003954931,"about_ca_topic_score_gemma":0.0001206615,"domain_scores_codex":[0.9983423,0.0004129418,0.0007034104,0.0002268993,0.00008083282,0.0002336134],"domain_scores_gemma":[0.9982743,0.001017118,0.0002617053,0.00007950086,0.0003255571,0.00004178624],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006660804,0.002633189,0.8501204,0.0008373484,0.0112107,0.002978631,0.001471641,0.00001481187,0.009880121,0.00459328,0.02125381,0.0883453],"study_design_scores_gemma":[0.04645967,0.003556345,0.6526658,0.00284745,0.005237398,0.1600004,0.009492441,0.00113843,0.05034639,0.001890673,0.06476641,0.001598599],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836096,0.01009431,0.00279118,0.001624393,0.0008753392,0.0005693349,0.0002039293,0.00002543594,0.0002065178],"genre_scores_gemma":[0.9956036,0.0002450554,0.003923827,0.00004980363,0.00003688082,0.00001053432,0.00001109187,0.0000165676,0.0001026057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1974546,"threshold_uncertainty_score":0.5103918,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01359610410727565,"score_gpt":0.2890731079822312,"score_spread":0.2754770038749556,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}